01/08/2023 - 11:03

PharmAust winds up subsidiary after contract loss

01/08/2023 - 11:03

Bookmark

Upgrade your subscription to use this feature.

PharmAust has appointed liquidators to wind-up its biotech subsidiary Epichem after it lost its lifeline contract and succumbed to cost pressures.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options